Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
783.18 | -49,6% | -28,91% | 705.179,49 | 0,68% | 2,63% |
|
NYSE:JNJ
Johnson & Johnson
|
151.27 | 0% | 0% | 364.058,36 | 3,21% | 2,71% |
|
NYSE:ABBV
AbbVie
|
164.56 | -22,18% | -11,89% | 290.591,2 | 3,73% | 7,03% |
|
LSE:AZN
AstraZeneca PLC
|
120.96 | 19,03% | 41,77% | 187.516,43 | 2,01% | 15,98% |
|
SWX:ROG
Roche Holding
|
237.10 | 25,34% | 40,63% | 191.277,25 | 4,05% | 0,43% |
|
NYSE:PFE
Pfizer
|
28.53 | 8,9% | 39,33% | 161.667,9 | 5,87% | -9,31% |
|
ENXTPA:SAN
Sanofi
|
89.16 | 19,34% | 38,31% | 111.460,42 | 4,22% | 8,19% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
987.27 | -29,95% | -23,98% | 106.512,12 | 0% | 13,9% |
|
LSE:GSK
GSK
|
17.75 | 7,44% | 23,26% | 72.385,16 | 3,27% | 0,79% |
|
NYSE:BMY
Bristol-Myers Squibb
|
43.36 | 64,24% | 74,73% | 87.895,06 | 5,45% | 13,54% |
